IRIS Accounts Production v25.1.4.42 03899033 director 1.5.24 31.3.25 31.3.25 false true false false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh038990332024-04-30038990332025-03-31038990332024-05-012025-03-31038990332023-04-30038990332023-05-012024-04-30038990332024-04-3003899033ns15:EnglandWales2024-05-012025-03-3103899033ns14:PoundSterling2024-05-012025-03-3103899033ns10:Director12024-05-012025-03-3103899033ns10:PrivateLimitedCompanyLtd2024-05-012025-03-3103899033ns10:SmallEntities2024-05-012025-03-3103899033ns10:AuditExempt-NoAccountantsReport2024-05-012025-03-3103899033ns10:SmallCompaniesRegimeForDirectorsReport2024-05-012025-03-3103899033ns10:SmallCompaniesRegimeForAccounts2024-05-012025-03-3103899033ns10:FullAccounts2024-05-012025-03-310389903312024-05-012025-03-3103899033ns5:CurrentFinancialInstruments2025-03-3103899033ns5:CurrentFinancialInstruments2024-04-3003899033ns5:Non-currentFinancialInstruments2025-03-3103899033ns5:Non-currentFinancialInstruments2024-04-3003899033ns5:ShareCapital2025-03-3103899033ns5:ShareCapital2024-04-3003899033ns5:RetainedEarningsAccumulatedLosses2025-03-3103899033ns5:RetainedEarningsAccumulatedLosses2024-04-3003899033ns10:RegisteredOffice2024-05-012025-03-3103899033ns5:NetGoodwill2024-05-012025-03-3103899033ns5:IntangibleAssetsOtherThanGoodwill2024-05-012025-03-3103899033ns5:NetGoodwill2024-04-3003899033ns5:NetGoodwill2025-03-3103899033ns5:NetGoodwill2024-04-3003899033ns5:LandBuildings2024-04-3003899033ns5:PlantMachinery2024-04-3003899033ns5:LandBuildings2024-05-012025-03-3103899033ns5:PlantMachinery2024-05-012025-03-3103899033ns5:LandBuildings2025-03-3103899033ns5:PlantMachinery2025-03-3103899033ns5:LandBuildings2024-04-3003899033ns5:PlantMachinery2024-04-3003899033ns5:WithinOneYearns5:CurrentFinancialInstruments2025-03-3103899033ns5:WithinOneYearns5:CurrentFinancialInstruments2024-04-3003899033ns5:Non-currentFinancialInstrumentsns5:AfterOneYear2025-03-3103899033ns5:Non-currentFinancialInstrumentsns5:AfterOneYear2024-04-30038990331ns10:Director12024-04-30038990331ns10:Director12023-04-30038990331ns10:Director12024-05-012025-03-31038990331ns10:Director12023-05-012024-04-30038990331ns10:Director12025-03-31038990331ns10:Director12024-04-30
REGISTERED NUMBER: 03899033 (England and Wales)



















Unaudited Financial Statements

for the Period

1 May 2024 to 31 March 2025

for

NEPRON LTD

NEPRON LTD (REGISTERED NUMBER: 03899033)






Contents of the Financial Statements
for the Period 1 May 2024 to 31 March 2025




Page

Balance Sheet 1

Notes to the Financial Statements 3


NEPRON LTD (REGISTERED NUMBER: 03899033)

Balance Sheet
31 March 2025

2025 2024
Notes £    £    £    £   
FIXED ASSETS
Intangible assets 4 - -
Tangible assets 5 1,597,972 1,019,820
1,597,972 1,019,820

CURRENT ASSETS
Stocks 70,565 72,315
Debtors 6 1,329,208 1,509,705
Cash at bank and in hand 519,958 837,334
1,919,731 2,419,354
CREDITORS
Amounts falling due within one year 7 388,003 752,271
NET CURRENT ASSETS 1,531,728 1,667,083
TOTAL ASSETS LESS CURRENT
LIABILITIES

3,129,700

2,686,903

CREDITORS
Amounts falling due after more than one
year

8

(297,955

)

-

PROVISIONS FOR LIABILITIES (10,310 ) (12,234 )
NET ASSETS 2,821,435 2,674,669

CAPITAL AND RESERVES
Called up share capital 20 20
Retained earnings 2,821,415 2,674,649
2,821,435 2,674,669

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the period ended 31 March 2025.

The members have not required the company to obtain an audit of its financial statements for the period ended 31 March 2025 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

NEPRON LTD (REGISTERED NUMBER: 03899033)

Balance Sheet - continued
31 March 2025


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the director and authorised for issue on 4 December 2025 and were signed by:





Jaskaran Singh Pannu - Director


NEPRON LTD (REGISTERED NUMBER: 03899033)

Notes to the Financial Statements
for the Period 1 May 2024 to 31 March 2025

1. STATUTORY INFORMATION

Nepron Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address are as below:

Registered number: 03899033

Registered office: Coalpool Pharmacy
140 Dartmouth Avenue
Coalpool
Walsall
West Midlands
WS3 1SP

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Goodwill
Goodwill, being the amount paid in connection with the acquisition of a business in 0, is being amortised evenly over its estimated useful life of nil years.

Intangible assets
Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Stocks
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Taxation
Taxation for the period comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.


NEPRON LTD (REGISTERED NUMBER: 03899033)

Notes to the Financial Statements - continued
for the Period 1 May 2024 to 31 March 2025

2. ACCOUNTING POLICIES - continued
Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the period end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Hire purchase and leasing commitments
Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the period was 17 (2024 - 17 ) .

4. INTANGIBLE FIXED ASSETS
Goodwill
£   
COST
At 1 May 2024
and 31 March 2025 128,876
AMORTISATION
At 1 May 2024
and 31 March 2025 128,876
NET BOOK VALUE
At 31 March 2025 -
At 30 April 2024 -

NEPRON LTD (REGISTERED NUMBER: 03899033)

Notes to the Financial Statements - continued
for the Period 1 May 2024 to 31 March 2025

5. TANGIBLE FIXED ASSETS
Plant and
Land and machinery
buildings etc Totals
£    £    £   
COST
At 1 May 2024 975,754 152,815 1,128,569
Additions 593,039 - 593,039
At 31 March 2025 1,568,793 152,815 1,721,608
DEPRECIATION
At 1 May 2024 4,879 103,870 108,749
Charge for period 7,190 7,697 14,887
At 31 March 2025 12,069 111,567 123,636
NET BOOK VALUE
At 31 March 2025 1,556,724 41,248 1,597,972
At 30 April 2024 970,875 48,945 1,019,820

6. DEBTORS
2025 2024
£    £   
Amounts falling due within one year:
Trade debtors 306,757 339,127
Other debtors 345,995 480,136
652,752 819,263

Amounts falling due after more than one year:
Other debtors 676,456 690,442

Aggregate amounts 1,329,208 1,509,705

7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2025 2024
£    £   
Trade creditors 186,830 245,139
Taxation and social security 158,508 457,966
Other creditors 42,665 49,166
388,003 752,271

8. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE
YEAR
2025 2024
£    £   
Bank loans 297,955 -

NEPRON LTD (REGISTERED NUMBER: 03899033)

Notes to the Financial Statements - continued
for the Period 1 May 2024 to 31 March 2025

9. DIRECTOR'S ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to a director subsisted during the period ended 31 March 2025 and the year ended 30 April 2024:

2025 2024
£    £   
Jaskaran Singh Pannu
Balance outstanding at start of period 690,442 (6,324 )
Amounts advanced 19,556 750,766
Amounts repaid (33,542 ) (54,000 )
Amounts written off - -
Amounts waived - -
Balance outstanding at end of period 676,456 690,442

Dividend Issued during the year £300,000 (£54,000 in 2024)